Doxorubicin inhibits TGF-β signaling in human lung carcinoma A549 cells
Authors:
- Yevhen FilyakYFYevhen Filyak
- Oksana FilyakOFOksana Filyak
- Serhiy SouchelnytskyiSSSerhiy Souchelnytskyi
- Rostyslav StoikaRSRostyslav Stoika
- 1 August 2008
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 590 (1-3) , 67-73
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Fine Tuning and Cross-talking of TGF-β Signal by Inhibitory SmadsBMB Reports, 2005
- New insights into TGF-β–Smad signallingTrends in Biochemical Sciences, 2004
- Jab1/CSN5, a Component of the COP9 Signalosome, Regulates Transforming Growth Factor β Signaling by Binding to Smad7 and Promoting Its DegradationMolecular and Cellular Biology, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- An Essential Role for Mad Homology Domain 1 in the Association of Smad3 with Histone Deacetylase Activity*Journal of Biological Chemistry, 2001
- Expression of Smad proteins in human colorectal cancerInternational Journal of Cancer, 1999
- Human Smad3 and Smad4 Are Sequence-Specific Transcription ActivatorsMolecular Cell, 1998
- TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997
- Adriamycin-induced inhibition of melanoma cell invasion is correlated with decreases in tumor cell motility and increases in focal contact formationClinical & Experimental Metastasis, 1993